- Home
- TYL vs TEVA Comparison
TYL vs TEVA Comparison
Compare TYL & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYL
- TEVA
- Stock Information
- Founded
- TYL 1966
- TEVA 1901
- Country
- TYL United States
- TEVA Israel
- Employees
- TYL N/A
- TEVA N/A
- Industry
- TYL Computer Software: Prepackaged Software
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- TYL Technology
- TEVA Health Care
- Exchange
- TYL Nasdaq
- TEVA Nasdaq
- Market Cap
- TYL 22.4B
- TEVA 21.2B
- IPO Year
- TYL N/A
- TEVA N/A
- Fundamental
- Price
- TYL $469.52
- TEVA $25.46
- Analyst Decision
- TYL Buy
- TEVA Strong Buy
- Analyst Count
- TYL 9
- TEVA 7
- Target Price
- TYL $666.78
- TEVA $25.86
- AVG Volume (30 Days)
- TYL 383.4K
- TEVA 13.4M
- Earning Date
- TYL 10-29-2025
- TEVA 11-05-2025
- Dividend Yield
- TYL N/A
- TEVA N/A
- EPS Growth
- TYL 31.32
- TEVA N/A
- EPS
- TYL 7.19
- TEVA 0.62
- Revenue
- TYL $2,298,292,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- TYL $10.91
- TEVA $4.11
- Revenue Next Year
- TYL $9.03
- TEVA $0.40
- P/E Ratio
- TYL $64.85
- TEVA $41.39
- Revenue Growth
- TYL 10.62
- TEVA 0.02
- 52 Week Low
- TYL $450.00
- TEVA $12.47
- 52 Week High
- TYL $661.31
- TEVA $26.38
- Technical
- Relative Strength Index (RSI)
- TYL 36.12
- TEVA 76.90
- Support Level
- TYL $456.00
- TEVA $23.61
- Resistance Level
- TYL $474.00
- TEVA $26.38
- Average True Range (ATR)
- TYL 15.17
- TEVA 0.84
- MACD
- TYL 0.23
- TEVA 0.45
- Stochastic Oscillator
- TYL 28.48
- TEVA 86.22
About TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.